Tesson L - Search Results

1

New lines of GFP transgenic rats relevant for regenerative medicine and gene therapy.

Remy S, Tesson L, Usal C, Menoret S, Bonnamain V, Nerriere-Daguin V, Rossignol J, Boyer C, Nguyen TH, Naveilhan P, Lescaudron L, Anegon I. Remy S, et al. Among authors: tesson l. Transgenic Res. 2010 Oct;19(5):745-63. doi: 10.1007/s11248-009-9352-2. Epub 2010 Jan 22. Transgenic Res. 2010. PMID: 20094912

2

Protection of rat endothelial cells from primate complement-mediated lysis by expression of human CD59 and/or decay-accelerating factor.

Charreau B, Cassard A, Tesson L, Le Mauff B, Navenot JM, Blanchard D, Lublin D, Soulillou JP, Anegon I. Charreau B, et al. Among authors: tesson l. Transplantation. 1994 Dec 15;58(11):1222-9. Transplantation. 1994. PMID: 7527603

3

Permanent expression of human CD59 and/or decay-accelerating factor by rat endothelial cells confers protection from human complement-mediated lysis.

Charreau B, Cassard A, Tesson L, Le Mauff B, Blanchard D, Lublin D, Soulillou JP, Anegon I. Charreau B, et al. Among authors: tesson l. Transplant Proc. 1995 Feb;27(1):336-7. Transplant Proc. 1995. PMID: 7533404 No abstract available.

4

Leukaemia Inhibitory Factor derived from rat colon carcinoma cells increases host susceptibility to tumour growth.

Burg C, Patry Y, Le Pendu J, Moreau M, Tesson L, Godard A, Soulillou JP, Meflah K, Anegon I. Burg C, et al. Among authors: tesson l. Cytokine. 1995 Nov;7(8):784-92. doi: 10.1006/cyto.1995.0094. Cytokine. 1995. PMID: 8664445

5

Transgenesis in rats: technical aspects and models.

Charreau B, Tesson L, Soulillou JP, Pourcel C, Anegon I. Charreau B, et al. Among authors: tesson l. Transgenic Res. 1996 Jul;5(4):223-34. doi: 10.1007/BF01972876. Transgenic Res. 1996. PMID: 8755162 Review.

6

Analysis of human CD59 tissue expression directed by the CMV-IE-1 promoter in transgenic rats.

Charreau B, Tesson L, Buscail J, Soulillou JP, Anegon I. Charreau B, et al. Among authors: tesson l. Transgenic Res. 1996 Nov;5(6):443-50. doi: 10.1007/BF01980209. Transgenic Res. 1996. PMID: 8840527

7

In vitro and in vivo gene transfer in the rat: characterization of recombinant adenoviral vectors for rat interleukin-4 or interleukin-10 cDNA.

David A, Cassard A, Tesson L, Blancho G, Sigalla J, Charreau B, Godfrin Y, Smit H, Le Mauff B, Soulillou JP, Anegon I. David A, et al. Among authors: tesson l. Transplant Proc. 1997 May;29(3):1750-1. doi: 10.1016/s0041-1345(97)00042-0. Transplant Proc. 1997. PMID: 9142259 No abstract available.

8

Production of transgenic rats for human regulators of complement activation.

Charreau B, Tesson L, Menoret S, Buscail J, Soulillou JP, Anegon I. Charreau B, et al. Among authors: tesson l. Transplant Proc. 1997 May;29(3):1770. doi: 10.1016/s0041-1345(97)81999-9. Transplant Proc. 1997. PMID: 9142267 No abstract available.

9

Adenovirus-mediated gene transfer in rat liver of interleukin 4 but not interleukin 10 produces severe acute hepatitis.

David A, Chetritt J, Coupel-Clauce H, Tesson L, Cassard A, Blancho G, Charreau B, Sigalla J, Buzelin F, Le Mauff B, Soulillou JP, Anegon I. David A, et al. Among authors: tesson l. Cytokine. 1997 Nov;9(11):818-29. doi: 10.1006/cyto.1997.0234. Cytokine. 1997. PMID: 9367542

10

Anti-adenovirus immune responses in rats are enhanced by interleukin 4 but not interleukin 10 produced by recombinant adenovirus.

David A, Coupel-Clauce H, Chetritt J, Tesson L, Cassard A, Charreau B, Soulillou JP, Anegon I. David A, et al. Among authors: tesson l. Hum Gene Ther. 1998 Aug 10;9(12):1755-68. doi: 10.1089/hum.1998.9.12-1755. Hum Gene Ther. 1998. PMID: 9721086

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

96 results

Search Page

Filters